Xconomy National

Archives

by in

Entry	Author	Date	Location
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race	Luke Timmerman	01/24/12	Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition	Luke Timmerman	12/15/11	Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News	Bruce V. Bigelow	11/03/11	San Diego
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut	Luke Timmerman	07/28/11	Boston
Vertex Adds New HepC Drugs for $60M	Luke Timmerman	06/13/11	Boston
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News	Bruce V. Bigelow	05/26/11	San Diego
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug	Luke Timmerman	05/23/11	Boston
Why Are Drugs Getting Such Weird Brand Names?	Luke Timmerman	05/09/11	National
Vertex Signs Boston Lease	Luke Timmerman	05/05/11	Boston
New Health IT Startup Targets Military Programs, Allylix Sniffs New Market for Nootkatone, Biocept Builds Team, & More San Diego Life Sciences News	Bruce V. Bigelow	05/05/11	San Diego
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News	Erin Kutz	04/29/11	Boston
Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug	Luke Timmerman	04/28/11	Boston
FDA Panel Meets Today on Vertex HepC Drug	Ryan McBride	04/28/11	Boston
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs	Luke Timmerman	04/26/11	Boston
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week	Luke Timmerman	04/25/11	Boston
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News	Erin Kutz	03/25/11	Boston
Date Set for Key Meeting on Vertex Drug	Ryan McBride	03/18/11	Boston
Vertex Stock Up 15 Percent on CF Data	Ryan McBride	02/23/11	Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug	Luke Timmerman	02/23/11	Boston
Genocea Announces New CEO, Pfizer to Add Jobs In MA, Ocular Raises $14M, and More Boston-Area Life Sciences News	Erin Kutz	02/04/11	Boston
The World’s Most Innovative City	Tim Rowe	02/02/11	Boston
Vertex Urges CDC to Recommend Hep C Screening, To Nudge “Second Tsunami” of Patients	Luke Timmerman	02/02/11	Boston
Heartland, Vertex Moving to Boston’s Waterfront	Gregory T. Huang	01/27/11	Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News	Erin Kutz	01/21/11	Boston
Page 1 of 3	next page »